H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Microbiology D-index 95 Citations 31,823 337 World Ranking 119 National Ranking 14
Medicine D-index 118 Citations 54,759 647 World Ranking 1705 National Ranking 167

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Disease

Her primary areas of study are Internal medicine, Immunology, Acquired immunodeficiency syndrome, Viral load and Cohort. Her Internal medicine research incorporates themes from Gastroenterology and Surgery. Her work deals with themes such as Cohort study and Confidence interval, which intersect with Immunology.

The Acquired immunodeficiency syndrome study combines topics in areas such as Odds ratio, Epidemiology, Proportional hazards model, Pediatrics and Risk factor. Her Viral load study integrates concerns from other disciplines, such as Chemotherapy, Regimen, Ritonavir, Survival analysis and Drug resistance. Caroline Sabin interconnects Life expectancy, Observational study, Gerontology and Cardiology in the investigation of issues within Cohort.

Her most cited work include:

  • Combination antiretroviral therapy and the risk of myocardial infarction (1490 citations)
  • Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. (1341 citations)
  • Class of antiretroviral drugs and the risk of myocardial infarction. (1269 citations)

What are the main themes of her work throughout her whole career to date?

Caroline Sabin mostly deals with Internal medicine, Immunology, Acquired immunodeficiency syndrome, Cohort and Viral load. The concepts of her Internal medicine study are interwoven with issues in Gastroenterology and Surgery. Her work focuses on many connections between Immunology and other disciplines, such as Antiretroviral therapy, that overlap with her field of interest in Intensive care medicine.

Her Acquired immunodeficiency syndrome research is multidisciplinary, incorporating elements of Proportional hazards model, Epidemiology, Pediatrics and Immunodeficiency. Caroline Sabin works mostly in the field of Viral load, limiting it down to topics relating to Efavirenz and, in certain cases, Nevirapine. Her Cohort study research incorporates elements of Prospective cohort study and Demography.

She most often published in these fields:

  • Internal medicine (44.83%)
  • Immunology (33.33%)
  • Acquired immunodeficiency syndrome (28.17%)

What were the highlights of her more recent work (between 2015-2021)?

  • Internal medicine (44.83%)
  • Cohort (22.09%)
  • Cohort study (16.67%)

In recent papers she was focusing on the following fields of study:

Caroline Sabin focuses on Internal medicine, Cohort, Cohort study, Acquired immunodeficiency syndrome and Viral load. In her study, which falls under the umbrella issue of Internal medicine, Drug resistance is strongly linked to Oncology. Her Cohort research includes themes of Men who have sex with men, Incidence, Immunology, Hazard ratio and Comorbidity.

Her work often combines Immunology and Cart studies. Her Cohort study study incorporates themes from Demography and Poisson regression. In her research, Atazanavir is intimately related to Prospective cohort study, which falls under the overarching field of Viral load.

Between 2015 and 2021, her most popular works were:

  • Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study (153 citations)
  • Increased brain-predicted aging in treated HIV disease (118 citations)
  • An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study (111 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Disease

Her main research concerns Internal medicine, Cohort, Acquired immunodeficiency syndrome, Cohort study and Viral load. Caroline Sabin has researched Internal medicine in several fields, including Poisson regression and Abacavir. Her Cohort research is multidisciplinary, incorporating perspectives in Epidemiology, Incidence, Demography, Life expectancy and Coinfection.

Her Acquired immunodeficiency syndrome research integrates issues from Hepatitis B, Pathology and Cobra. The various areas that Caroline Sabin examines in her Cohort study study include Body mass index, Men who have sex with men, Physical therapy, Pediatrics and Drug resistance. Her biological study spans a wide range of topics, including Young adult, Gerontology, Lopinavir and Surgery.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Combination antiretroviral therapy and the risk of myocardial infarction

Nina Friis-Møller;Caroline A Sabin;Rainer Weber;Antonella d'Arminio Monforte.
The New England Journal of Medicine (2003)

2383 Citations

Class of antiretroviral drugs and the risk of myocardial infarction.

Nina Friis-Moller;Peter Reiss;Caroline A. Sabin;Rainer Weber.
The New England Journal of Medicine (2007)

2026 Citations

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

Matthias Egger;Margaret May;Geneviève Chene;Andrew N. Phillips.
The Lancet (2002)

1977 Citations

Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study

Rainer Weber;Caroline A Sabin;Nina Friis-Møller;Peter Reiss.
JAMA Internal Medicine (2006)

1394 Citations

Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD study

Nina Friis-Møller;Rainer Weber;Peter Reiss;Rodolphe Thiebaut.
AIDS (2003)

1302 Citations

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

Caroline Sabin;Signe Westring Worm;Rainer Weber.
The Lancet (2008)

1063 Citations

Natural history and outcome in systemic AA amyloidosis.

Helen J. Lachmann;Hugh J.B. Goodman;Janet A. Gilbertson;J. Ruth Gallimore.
The New England Journal of Medicine (2007)

919 Citations

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

Colette J Smith;Lene Ryom;Rainer Weber;Philippe Morlat.
The Lancet (2014)

794 Citations

Targeting C-reactive protein for the treatment of cardiovascular disease

Mark B Pepys;Gideon M Hirschfield;Glenys A Tennent;J Ruth Gallimore.
Nature (2006)

789 Citations

Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study

Signe Westring Worm;Caroline Sabin;Rainer Weber;Peter Reiss.
The Journal of Infectious Diseases (2010)

745 Citations

Editorial Boards

HIV Medicine
(Impact Factor: 3.094)

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Caroline Sabin

Jens D. Lundgren

Jens D. Lundgren

Rigshospitalet

Publications: 209

Andrew N. Phillips

Andrew N. Phillips

University College London

Publications: 173

Dominique Costagliola

Dominique Costagliola

Université Paris Cité

Publications: 164

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 150

Amy C. Justice

Amy C. Justice

Yale University

Publications: 144

Richard D. Moore

Richard D. Moore

Johns Hopkins University

Publications: 140

Robert S. Hogg

Robert S. Hogg

Simon Fraser University

Publications: 132

Manuel Battegay

Manuel Battegay

University Hospital of Basel

Publications: 128

Amanda Mocroft

Amanda Mocroft

University College London

Publications: 127

Peter Reiss

Peter Reiss

University of Amsterdam

Publications: 123

David A. Cooper

David A. Cooper

Pfizer (United States)

Publications: 118

Matthias Cavassini

Matthias Cavassini

University of Lausanne

Publications: 117

Hansjakob Furrer

Hansjakob Furrer

University of Bern

Publications: 117

Bruno Ledergerber

Bruno Ledergerber

University of Zurich

Publications: 113

Matthew Law

Matthew Law

UNSW Sydney

Publications: 112

Matthias Egger

Matthias Egger

University of Bern

Publications: 112

Something went wrong. Please try again later.